Ortho-Clinical Diagnostics, Inc.
Records under this name other than the patents Ortho-Clinical Diagnostics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 105 patents it holds.
Back to Ortho-Clinical Diagnostics, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,655,233 | Optimal Placement of a Robust Solvent/Detergent Process Post Viral Ultrafiltration of an Immune Gamma Globulin Formerly held In force · High confidence | In force | High confidence | |
| US 9,372,187 | Detection Method and Determination Method for Detection Target Held by another company In force · High confidence | In force | High confidence | |
| US 9,063,144 | Detection Method and Quantification Method for Target Substance Held by another company In force · High confidence | In force | High confidence | |
| US 11,559,540 | Method of Determining Acute Myeloid Leukemia Response to Treatment with Farnesyltransferase Inhibitors Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 9,012,648 | Haptens of Risperidone and Paliperidone Formerly held In force · High confidence | In force | High confidence | |
| US 9,303,041 | Haptens of Olanzapine Formerly held In force · High confidence | In force | High confidence | |
| US 9,304,126 | Haptens of Quetiapine Formerly held In force · High confidence | In force | High confidence | |
| US 9,751,953 | Antibodies to Risperidone Haptens and Use Thereof Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 9,850,318 | Antibodies to Quetiapine Haptens and Use Thereof Formerly held In force · High confidence | In force | High confidence | |
| US 10,288,631 | Antibodies to Quetiapine and Use Thereof Formerly held In force · Low confidence | In force | Low confidence |